Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 6.10.2023MEDOCHEMIE Ltd. (MOE)87372MEDOZIL 5 mg (tbl flm 28x5 mg (blis.PVC/Al))6.10.2023R
 6.10.2023MEDOCHEMIE Ltd. (MOE)8755BONELAR 30 mg tvrdé gastrorezistentné kapsuly (cps end 28x30 mg (blis.PA/Al/PVC/Al))6.10.2023R
 6.10.2023MEDOCHEMIE Ltd. (MOE)2849BMANTOMED 20 mg (tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al))27.9.2023O
 6.10.2023MEDOCHEMIE Ltd. (MOE)5204CDALTEX 50 mg/850 mg filmom obalené tablety (tbl flm 60x50 mg/850 mg (blis.Al/Al-OPA/Al/PVC))27.9.2023U
 6.10.2023MEDOCHEMIE Ltd. (MOE)53522RAMIMED 5 mg (tbl 30x5 mg (blis.Al/Al/PA/PVC))27.9.2023O
 6.10.2023MEDOCHEMIE Ltd. (MOE)5756CDALMEVIN 50 mg tablety (tbl 60x50 mg (blis.Al/Al))27.9.2023U
 6.10.2023MEDOCHEMIE Ltd. (MOE)67031MEDOFLUCON 150 mg (cps dur 10x150 mg (blis.PVC/Al))27.9.2023R
 6.10.2023MEDOCHEMIE Ltd. (MOE)7672BSAGILIA 1mg tablety (tbl 28x1 mg (blis.PVC/PE/PVDC/Al))27.9.2023O
 6.10.2023MEDOCHEMIE Ltd. (MOE)7675BSAGILIA 1mg tablety (tbl 100x1 mg (blis.PVC/PE/PVDC/Al))27.9.2023O
 6.10.2023MEDOCHEMIE Ltd. (MOE)79193MEDOPEXOL 0,18 mg (tbl 30x0,18 mg (blis. OPA/Al/PVC/Al))27.9.2023O
 6.10.2023MEDOCHEMIE Ltd. (MOE)8735DBROXIVAN 3 mg/ml perorálny roztok (sol por 1x100 ml/300 mg (fľ.skl.hnedá+plast.odmer.))27.9.2023R
 6.10.2023MEDOCHEMIE Ltd. (MOE)87372MEDOZIL 5 mg (tbl flm 28x5 mg (blis.PVC/Al))27.9.2023O
 6.10.2023MEDOCHEMIE Ltd. (MOE)8755BONELAR 30 mg tvrdé gastrorezistentné kapsuly (cps end 28x30 mg (blis.PA/Al/PVC/Al))27.9.2023O
 6.10.2023BELUPO, s.r.o. (BLU-SK)20379URUTAL 24 mg (tbl 50x24 mg (blis.PVC/PVDC/Al))6.10.2023R
 6.10.2023BELUPO, s.r.o. (BLU-SK)38084URUTAL 16 mg (tbl 60x16 mg (blis.PVC/PVDC/Al))6.10.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)